Researchers use large-scale human genetic studies to identify drug targets important for managing COVID-19 in its early…
Scientists from the Beltrao Group at EMBL-EBI and collaborators identified drug targets common to SARS-CoV-2, SARS-CoV-1, and MERS-CoV, three…
The virtual EMBL Conference ‘SARS-CoV-2: Towards a New Era in Infection Research’ explored the importance of fundamental research, collaboration,…
Open Targets welcomes new Informatics Science…
The infectious disease commonly known as flu is caused by the influenza virus. It spreads around the world in seasonal outbreaks, causing millions of…
EMBL Hamburg and Tara raise awareness of the risks of microplastic pollution and global…
Large CRISPR screen prioritises hundreds of promising genes for personalised cancer…
New director drives drug discovery partnership…
Pharmaceutical company Sanofi strengthens drug targets discovery collaboration Open…
EMBL and Promega collaborate to train young…
New partner strengthens drug discovery…
ERC grantee Stephen Cusack shares his vision for the next ten…
Looking for past print editions of EMBLetc.? Browse our archive, going back 20 years.
EMBLetc. archive